SITC’s Guide to Managing Immunotherapy Toxicity

The Society for Immunotherapy of Cancer's handbook, SITC’s Guide to Managing Immunotherapy Toxicity , is a practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Separated into two parts, Part I contains chapter-based overviews of immune checkpoint inhibitors in the clinic, starting with anti-CTLA4 agents, anti-PD1/PD-L1 agents, and approved immunotherapeutic combinations. These chapters cover relevant mechanisms of action, indications, and toxiciti